Of note, although we developed this predictive model according to the peak levels of TNF-α and CRP at 1 week following CAR-T therapy, it is still applicable at any time within 1 week post-CAR-T infusion, even before the occurrence of CRS. This evidence concerns the gene TNF and congenital rubella syndrome.